Has Cuba discovered a cancer vaccine?

Has Cuba discovered a cancer vaccine?HAVANA, 16. Jan. Cuban researchers have announced that CIMAVAX EGF, a Cuban vaccine against lung cancer has proven its effectiveness.

Researchers at the Center for Molecular Immunology in Havana have developed the Cimavax EGF therapeutic vaccine, which is the result of 25 years of research into smoking-related diseases.

Dr. Gisela Gonzalez, who led the team of researchers who created the vaccine, believes that with this drug, lung cancer could become a controllable chronic disease because the vaccine promotes the generation of antibodies against the proteins that trigger proliferation. without control of carcinogenic cells.

This vaccine is not intended to prevent the onset of the disease. It is therapeutic, and is for this reason intended for people already suffering from non-small cell cancers arrived at advanced stages. Clearly, the vaccine has the effect of slowing down the progression of tumors, but does not replace the care provided during the occurrence of such cancers.

CIMAvax is a vaccine that has been developed in Cuba. It is currently undergoing a first phase of clinical trials in the United States at the Roswell Park Center.

Available in five 5 Outside Cuba, the vaccine is available in Peru, Paraguay, Colombia and Bosnia and Herzegovina.